← All indications
Adenocarcinoma, Mucinous
An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)
Subtype terms (1)
More specific conditions that are subtypes of Adenocarcinoma, Mucinous in the MeSH hierarchy.
- Pseudomyxoma Peritonei
16 drugs (15 approved, 1 experimental)
Drugs by status
Phase 3 trials (5)
Phase 2 trials (5)
Phase 1 trials (1)
Organizations
Organization Involved with Phase 3 Indications (8)
Organization Involved with Phase 2 Indications (20)
- Amgen
- Genentech
- Sanofi
- University of Pennsylvania
- Mercy Medical Center
- Ohio State University
- Rutgers University
- University of Southern California
- Wake Forest University
- Mayo Clinic
- Icahn School of Medicine at Mount Sinai
- University of Texas at Houston
- State University of New York, Buffalo
- University of New South Wales
- Gateway for Cancer Research
- Yeshiva University
- Klus Pharma Inc.
- Chinese Academy of Medical Sciences
- Mucpharm Pty Ltd
- ThermaSolutions Inc.
Organization Involved with Phase 1 Indications (13)
- Millennium Pharmaceuticals
- Precision Biologics, Inc
- Case Western Reserve University
- Temple University
- Johns Hopkins University
- University of Kentucky
- University of Rochester
- Virginia Commonwealth University
- Stony Brook University
- University of California, Davis
- University of California, San Diego
- University of Chicago
- Vanderbilt University
Organization Involved with Other Experimental Indications (1)